Related references
Note: Only part of the references are listed.Gene Silencing by Gold Nanoshell-Mediated Delivery and Laser-Triggered Release of Antisense Oligonucleotide and siRNA
Ryan Huschka et al.
ACS NANO (2012)
Regulation and function of the RSK family of protein kinases
Yves Romeo et al.
BIOCHEMICAL JOURNAL (2012)
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Edita Aksamitiene et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Fas death receptor signalling: roles of Bid and XIAP
T. Kaufmann et al.
CELL DEATH AND DIFFERENTIATION (2012)
Association of Nuclear YB-1 Localization With Lung Resistance-related Protein and Epidermal Growth Factor Receptor Expression in Lung Cancer
Akira Hyogotani et al.
CLINICAL LUNG CANCER (2012)
Role of cold shock Y-box protein-1 in inflammation, atherosclerosis and organ transplant rejection
Ute Raffetseder et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Cold shock Y-box protein-1 participates in signaling circuits with auto-regulatory activities
Sabine Brandt et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop
Tobias Sinnberg et al.
EXPERIMENTAL DERMATOLOGY (2012)
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Antonella De Luca et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth
Annette Lasham et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
DNA Damage Signals through Differentially Modified E2F1 Molecules To Induce Apoptosis
Jasmyne Carnevale et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh et al.
NATURE (2012)
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition
A. Astanehe et al.
ONCOGENE (2012)
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity
Nicola Montgomery et al.
BREAST CANCER RESEARCH (2012)
Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells
Masaki Shiota et al.
BJU INTERNATIONAL (2011)
YB-1 Bridges Neural Stem Cells and Brain Tumor-Initiating Cells via Its Roles in Differentiation and Cell Growth
Abbas Fotovati et al.
CANCER RESEARCH (2011)
Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
Assaf C. Bester et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications
Katrien De Bock et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Newly identified aspects of tumor suppression by RB
Patrick Viatour et al.
DISEASE MODELS & MECHANISMS (2011)
Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma
Huiling Shen et al.
EXPERIMENTAL HEMATOLOGY (2011)
The promise and challenges of targeting RSK for the treatment of cancer
Anna L. Stratford et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Targeting RSK2 in human malignancies
Sumin Kang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
ERK1/2 Phosphorylate Raptor to Promote Ras-dependent Activation of mTOR Complex 1 (mTORC1)
Audrey Carriere et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
p53 Suppresses Lung Resistance-Related Protein Expression Through Y-Box Binding Protein 1 in the MCF-7 Breast Tumor Cell Line
Baolei Tian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Metabolic regulation by p53
Oliver D. K. Maddocks et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
E2F transcription factor-1 regulates oxidative metabolism
Emilie Blanchet et al.
NATURE CELL BIOLOGY (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer
V. Moncho-Amor et al.
ONCOGENE (2011)
YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
A. H. Davies et al.
ONCOGENE (2011)
Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of Antibody
Adele G. Woolley et al.
PLOS ONE (2011)
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Qian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
pRB, a tumor suppressor with a stabilizing presence
Amity L. Manning et al.
TRENDS IN CELL BIOLOGY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Molecular interactions in cancer cell metastasis
Susan A. Brooks et al.
ACTA HISTOCHEMICA (2010)
YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis
David H. Lovett et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
Karen To et al.
CANCER RESEARCH (2010)
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Aaron J. Schetter et al.
CARCINOGENESIS (2010)
Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
David Engelmann et al.
DRUG RESISTANCE UPDATES (2010)
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells
Yuji Basaki et al.
EUROPEAN JOURNAL OF CANCER (2010)
The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-beta in Normal and Malignant Mammary Epithelial Cells
Molly A. Taylor et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing
S. B. Cohen et al.
ONCOGENE (2010)
The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells
J. Dhillon et al.
ONCOGENE (2010)
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
J. Kalra et al.
ONCOGENE (2010)
Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1
L. C. Cobbold et al.
ONCOGENE (2010)
Identification of Y-Box Binding Protein 1 As a Core Regulator of MEK/ERK Pathway-Dependent Gene Signatures in Colorectal Cancer Cells
Karsten Juerchott et al.
PLOS GENETICS (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer
Edgar Dahl et al.
BMC CANCER (2009)
Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
Valentina Evdokimova et al.
CANCER CELL (2009)
Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma
Brian P. Adley et al.
GYNECOLOGIC ONCOLOGY (2009)
YB-1 Acts as a Ligand for Notch-3 Receptors and Modulates Receptor Activation
Thomas Rauen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase
Yuanyuan Gao et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1
A. Astanehe et al.
ONCOGENE (2009)
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells
M. R. Finkbeiner et al.
ONCOGENE (2009)
The angiogenic switch in carcinogenesis
Vanessa Baeriswyl et al.
SEMINARS IN CANCER BIOLOGY (2009)
Apoptosis and cancer: the genesis of a research field
Thomas G. Cotter
NATURE REVIEWS CANCER (2009)
Caspase activation cascades in apoptosis
Susan E. Logue et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma
Manik Chatterjee et al.
BLOOD (2008)
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
Timothy C. Hallstrom et al.
CANCER CELL (2008)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
Cathy Lee et al.
CANCER RESEARCH (2008)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription
Kyunghwan Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Y-box protein-1 controls transforming growth factor-β1 translation in proximal tubular cells
D. J. Fraser et al.
KIDNEY INTERNATIONAL (2008)
Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1
Ranajoy Chattopadhyay et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration
Ke Zen et al.
PLOS ONE (2008)
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart et al.
NATURE REVIEWS CANCER (2008)
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Anna L. Stratford et al.
BREAST CANCER RESEARCH (2008)
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi et al.
BREAST CANCER RESEARCH (2008)
Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice
Regina Krohn et al.
CIRCULATION (2007)
The phosphoinositide-dependent kinase-1 inhibitor 2-AminoN-[ 4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1yl] phenyl]-acetamide (OSU-03012) prevents y-box binding protein-1 from inducing epidermal growth factor receptor
K. To et al.
MOLECULAR PHARMACOLOGY (2007)
YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site
Shaija Samuel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance
Birgit Schittek et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells
Y. Basaki et al.
ONCOGENE (2007)
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors
Damien Faury et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer
Charles Bailey et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking
Heather L. Wiernan et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
RB and cell cycle progression
C. Giacinti et al.
ONCOGENE (2006)
E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to ras inhibition
Roy Blum et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2
Joyce Wu et al.
CANCER RESEARCH (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species
V Evdokimova et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis
Bernard Tetu et al.
BREAST CANCER RESEARCH (2006)
Some p53-binding proteins that can function as arbiters of life and death
A. W. Braithwaite et al.
CELL DEATH AND DIFFERENTIATION (2006)
Y-box factor YB1 controls p53 apoptotic function
C Homer et al.
ONCOGENE (2005)
Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3β and repression of the human VEGF promoter
LS Coles et al.
FEBS LETTERS (2005)
Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease
CRC van Roeyen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells
BW Sutherland et al.
ONCOGENE (2005)
Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma
K Matoba et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mining for regulatory programs in the cancer transcriptome
DR Rhodes et al.
NATURE GENETICS (2005)
YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence
ZH Lu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification
S Bergmann et al.
CANCER RESEARCH (2005)
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
C Gessner et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders
E Klenova et al.
JOURNAL OF NEUROSCIENCE (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Molecular mechanisms of caspase regulation during apoptosis
SJ Riedl et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
YB-11s upregulated during prostate cancer tumor progression and increases P-glycoprotein activity
P Giménez-Bonafé et al.
PROSTATE (2004)
Transcriptional regulation of cadherins during development and carcinogenesis
HC Peinado et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Specificity in the activation and control of transcription factor E2F-dependent apoptosis
TC Hallstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor
A Lasham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β pathway in HepG2 cells
D Mottet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing
ZY Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Nuclear localization of Y-box factor YB1 requires wild-type p53
YF Zhang et al.
ONCOGENE (2003)
Links between signal transduction, transcription and adhesion in epithelial bud development
C Jamora et al.
NATURE (2003)
Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma
Y Oda et al.
JOURNAL OF PATHOLOGY (2003)
A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts
LS Coles et al.
NUCLEIC ACIDS RESEARCH (2002)
Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells
PR Mertens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1
M Janz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4
E Stickeler et al.
EMBO JOURNAL (2001)
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression
T Okamoto et al.
ONCOGENE (2000)
Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial
OI Stenina et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Regulation of the human fas promoter by YB-1, Purα and AP-1 transcription factors
A Lasham et al.
GENE (2000)
Share Paper
